Company intelligence / Profile preview

Aphea.Bio

Ghent/Zwijnaarde, Flanders, Belgiumaphea.org ↗

Ownership: Private
Employees: ~51
Development stage: Commercial

Overview

No clinical results reported—focus is on agricultural biologicals. Advanced products include biostimulants and biofungicides. Pipeline includes candidates in bioherbicide and bioinsecticide segments.

Therapeutic areas: Other
Modalities: Microbial therapy
Industry: Agriculture & AgTech

Drug pipeline

3 assets

ACTIV

Commercial

Indications: Agricultural biostimulant

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Aphea.Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aphea.Bio.

Explore the full profile